A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...
Scientists have hailed a promising breakthrough in drugs used to treat Alzheimer’s disease at the University of Southampton ...
Nearly 7 million Americans have Alzheimer's disease, a specific type of dementia, and a new study is highlighting two new risk factors to be aware of. In the study, published Wednesday in The Lancet, ...